Patents by Inventor John F. McElroy

John F. McElroy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

Patent number: 11179370

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Grant

Filed: March 4, 2020

Date of Patent: November 23, 2021

Assignee: Jenrin Discovery, LLC

Inventors: John F McElroy, Robert J. Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING DISEASE CONDITIONS, INCLUDING METABOLIC DISORDERS AND CANCERS

Publication number: 20210023054

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Application

Filed: March 4, 2020

Publication date: January 28, 2021

Inventors: John F. McElroy, Robert J. Chorvat
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Patent number: 10617673

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Grant

Filed: May 29, 2018

Date of Patent: April 14, 2020

Assignee: Jenrin Discovery, LLC

Inventors: John F McElroy, Robert J Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES

Publication number: 20180353478

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Application

Filed: May 29, 2018

Publication date: December 13, 2018

Inventors: John F. McElroy, Robert J. Chorvat
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Patent number: 9987253

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Grant

Filed: December 13, 2016

Date of Patent: June 5, 2018

Assignee: JENRIN DISCOVERY, INC.

Inventors: John F McElroy, Robert J Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES

Publication number: 20170182004

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Application

Filed: December 13, 2016

Publication date: June 29, 2017

Inventors: John F. McElroy, Robert J. Chorvat
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Patent number: 9517228

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Grant

Filed: September 3, 2015

Date of Patent: December 13, 2016

Assignee: Jenrin Discovery, Inc.

Inventors: John F McElroy, Robert J Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES

Publication number: 20160058736

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Application

Filed: September 3, 2015

Publication date: March 3, 2016

Inventors: John F McElroy, Robert J Chorvat
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

Patent number: 9133127

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Grant

Filed: February 27, 2014

Date of Patent: September 15, 2015

Assignee: Jenrin Discovery, Inc.

Inventors: John F. McElroy, Robert J. Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES

Publication number: 20150157605

Abstract: The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, hepatic disorders, and/or cardiometabolic disorders.

Type: Application

Filed: October 6, 2014

Publication date: June 11, 2015

Inventors: John F. McElroy, Robert J. Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING DISEASE CONDITIONS, INCLUDING METABOLIC DISORDERS AND CANCERS

Publication number: 20140329875

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Application

Filed: February 27, 2014

Publication date: November 6, 2014

Applicant: JENRIN DISCOVERY

Inventors: John F. McElroy, Robert J. Chorvat
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Patent number: 8853252

Abstract: The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, hepatic disorders, and/or cardiometabolic disorders.

Type: Grant

Filed: March 7, 2012

Date of Patent: October 7, 2014

Assignee: Jenrin Discovery, Inc.

Inventors: John F. McElroy, Robert J. Chorvat
4-quinolinemethanols as anti-malarial agents

Patent number: 8716265

Abstract: The present invention relates to substituted 4-qinolinemethanols and pharmaceutical compositions thereof and methods of using the same for treating of malaria, tuberculosis, and other infectious diseases.

Type: Grant

Filed: November 18, 2011

Date of Patent: May 6, 2014

Assignee: Jenrin Discovery, Inc.

Inventors: John F. McElroy, Robert J. Chorvat, David Nugiel
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Patent number: 8648072

Abstract: The present invention provides novel pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Grant

Filed: June 29, 2012

Date of Patent: February 11, 2014

Assignee: Jenrin Discovery, Inc.

Inventors: John F. McElroy, Robert J. Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING DISEASE CONDITIONS, INCLUDING METABOLIC DISORDERS AND CANCERS

Publication number: 20140031404

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Application

Filed: July 24, 2013

Publication date: January 30, 2014

Inventors: John F. McElroy, Robert J. Chorvat
Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Patent number: 8580768

Abstract: The present invention provides novel pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Grant

Filed: November 18, 2011

Date of Patent: November 12, 2013

Assignee: Jenrin Discovery, Inc.

Inventors: John F McElroy, Robert J Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES

Publication number: 20130005784

Abstract: The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, and/or cardiometabolic disorders.

Type: Application

Filed: December 23, 2011

Publication date: January 3, 2013

Applicant: JENRIN DISCOVERY

Inventors: John F. McElroy, Robert J. Chorvat
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Patent number: 8334282

Abstract: The present invention provides novel substituted amino-azetidines that are useful as cannabinoid receptor antagonists/inverse agonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, dyslipidemias, cardiovascular disorders, hepatic disorders, and a combination thereof.

Type: Grant

Filed: July 6, 2010

Date of Patent: December 18, 2012

Assignee: Jenrin Discovery, Inc.

Inventors: John F. McElroy, Robert J. Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES

Publication number: 20120264797

Abstract: The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, hepatic disorders, and/or cardiometabolic disorders.

Type: Application

Filed: March 7, 2012

Publication date: October 18, 2012

Applicant: JENRIN DISCOVERY

Inventors: John F. McElroy, Robert J. Chorvat
CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES

Publication number: 20120264754

Abstract: The present invention provides novel pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Application

Filed: June 29, 2012

Publication date: October 18, 2012

Applicant: JENRIN DISCOVERY

Inventors: John F. McElroy, Robert J. Chorvat

1 2 3 next